Matrix metalloproteinase-2 contributes to increased platelet reactivity in patients with metastatic prostate cancer: a preliminary study

Thromb Res. 2003;112(1-2):59-64. doi: 10.1016/j.thromres.2003.10.012.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Biomarkers, Tumor / blood*
  • Blood Platelets / metabolism*
  • Humans
  • Male
  • Matrix Metalloproteinase 2 / blood*
  • Matrix Metalloproteinase 2 / metabolism
  • Middle Aged
  • Neoplasm Metastasis
  • Platelet Activation*
  • Prostatic Neoplasms / blood*
  • Prostatic Neoplasms / enzymology*
  • Risk Assessment / methods*

Substances

  • Biomarkers, Tumor
  • Matrix Metalloproteinase 2